Search hospitals > Louisiana > Monroe
Ochsner LSU Health Monroe Medical Center
Claim this profileMonroe, Louisiana 71202
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Tumors
96 reported clinical trials
7 medical researchers
Summary
Ochsner LSU Health Monroe Medical Center is a medical facility located in Monroe, Louisiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Tumors and other specialties. Ochsner LSU Health Monroe Medical Center is involved with conducting 96 clinical trials across 184 conditions. There are 7 research doctors associated with this hospital, such as Gary V. Burton, Samip Master, Kavitha Beedupalli, and Poornima Ramadas.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Gary V. BurtonLSU Health Sciences Center at Shreveport1 year of reported clinical research
Expert in Breast Cancer
Studies Cancer
22 reported clinical trials
40 drugs studied
Samip MasterLSU Health Sciences Center at Shreveport3 years of reported clinical research
Studies Plasma Cell Neoplasms
Studies Multiple Myeloma
5 reported clinical trials
13 drugs studied
Kavitha BeedupalliOchsner LSU Health Monroe Medical Center9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
7 drugs studied
Poornima RamadasLSU Health Sciences Center at Shreveport4 years of reported clinical research
Studies Lymphoma
Studies Leukemia
4 reported clinical trials
14 drugs studied
Clinical Trials running at Ochsner LSU Health Monroe Medical Center
Diffuse Large B-Cell Lymphoma
Non-Small Cell Lung Cancer
Breast Cancer
Multiple Myeloma
Lung Cancer
Lymphoma
Plasma Cell Neoplasms
Cancer
B-Cell Lymphoma
ALK Gene Rearrangement
Oral Azacitidine + R-miniCHOP
for Diffuse Large B-Cell Lymphoma
This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone \[R-miniCHOP\]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. R-miniCHOP includes a monoclonal antibody (a type of protein), called rituximab, which attaches to the lymphoma cells and may help the immune system kill these cells. R-miniCHOP also includes prednisone which is an anti-inflammatory medication and a combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Combining oral azacitidine with R-miniCHOP may shrink the cancer or extend the time without disease symptoms coming back or extend patient's survival when compared to R-miniCHOP alone.
Recruiting1 award Phase 2 & 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ochsner LSU Health Monroe Medical Center?
Ochsner LSU Health Monroe Medical Center is a medical facility located in Monroe, Louisiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Tumors and other specialties. Ochsner LSU Health Monroe Medical Center is involved with conducting 96 clinical trials across 184 conditions. There are 7 research doctors associated with this hospital, such as Gary V. Burton, Samip Master, Kavitha Beedupalli, and Poornima Ramadas.